Get the Stockscreener App
229.60
1.07%
2.435
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $229.60, with a volume of 128.20K.
It is up +1.07% in the last 24 hours and up +6.30% over the past month.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$227.17
Open:
$226.03
24h Volume:
128.20K
Relative Volume:
0.25
Market Cap:
$19.05B
Revenue:
$12.49B
Net Income/Loss:
$449.50M
P/E Ratio:
30.70
EPS:
7.48
Net Cash Flow:
$852.30M
1W Performance:
+0.67%
1M Performance:
+6.30%
6M Performance:
+14.05%
1Y Performance:
+9.22%
1-Day Range:
$224.64
$229.52
1-Week Range:
$224.64
$231.92
52-Week Range:
$191.97
$239.50
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Insider Sell: Laboratory Corp Of America Holdings - Marketscreener.com
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience - Yahoo Finance
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Lab Design Tool Executives to Speak at Future Labs LIVE US in Philadelphia with CIC and Labcorp, and at LAFM Summit 2024 in Boston with Eli Lilly - Yahoo Finance
Labcorp's quarterly results beat on diagnostic tests demand - MSN
HSBC Upgrades Labcorp Holdings (LH) - MSN
Decoding Labcorp Holdings Inc (LH): A Strategic SWOT Insight - Yahoo Finance
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp up 7% on top and bottom line quarterly beats - MSN
Navigating Cancer, Inc. announced that it has received $26.000098 million in funding from Merck Global Health Innovation Fund, LLC, TT Capital Partners, LLC, ORIX Growth Capital, Rustic Canyon Partners, Laboratory Corporation of America Holdings and ot - Marketscreener.com
Labcorp Declares Quarterly Dividend - GuruFocus.com
LabCorp director Kerrii B. Anderson sells $230,000 in stock By Investing.com - Investing.com South Africa
LabCorp director Kerrii B. Anderson sells $230,000 in stock - Investing.com India
Labcorp Worker Can Seek Pay for Disability Claim in State Court - Bloomberg Law
Labcorp (LH) Q3 Earnings and Revenues Surpass Estimates - MSN
Labcorp Holdings Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Laboratory Corp stock hits 52-week high at $238.93 amid robust growth - Investing.com Canada
Earnings call: Labcorp reports growth and strategic advances in Q3 2024 - Investing.com Nigeria
Earnings call: Labcorp reports growth and strategic advances in Q3 2024 By Investing.com - Investing.com South Africa
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2024 Earnings Call Transcript - MSN
Compared to Estimates, Labcorp (LH) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Labcorp : Supplemental Earnings Information - Marketscreener.com
Labcorp Announces 2024 Third Quarter Results - BioSpace
Labcorp beats quarterly estimates on diagnostic test demand - Marketscreener.com
Labcorp: Q3 Earnings Snapshot - Marketscreener.com
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Earnings Flash (LH) LABCORP Posts Q1 Revenue $3.78B, vs. Street Est of $3.70B - Marketscreener.com
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - Yahoo Finance
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock - MSN
LabCorp started at neutral by Piper Sandler, price run up cited - MSN
Is Labcorp Holdings (NYSE:LH) Using Too Much Debt? - Simply Wall St
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Nowdiagnostics partners with Labcorp to distribute at-home syphilis test - BioWorld Online
Labcorp Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
55K Labcorp 401(k) Participants Get Class Cert. In Fees Suit - Law360
Labcorp (LH) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Labcorp Holdings Inc. stock rises Wednesday, still underperforms market - MarketWatch
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - Marketscreener.com
NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only Marketing Authorized Over-The-Counter Syphilis Test In The U.S. - XM
LabCorp Gets Google Health Info Suit Sent To Arbitration - Law360
U.S. Employer and Workplace Drug Testing Market Report 2024, Featuring First Advantage, Labcorp, Dragerwerk, Quest Diagnostics, Cordant Health Solutions, HireRight, Omega Laboratories & Psychemedics - Yahoo Finance
Labcorp Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
LabCorp to Settle Suit Over Alleged Google Patient Data Sharing - Bloomberg Law
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Marketscreener.com
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):